Evidence supporting the use of: Honeysuckle
For the health condition: Phlebitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Honeysuckle (Lonicera japonica) has a long history of use in traditional Chinese medicine (TCM), where it is known as "Jin Yin Hua." In TCM, honeysuckle is commonly used for its purported heat-clearing and detoxifying properties, making it a popular ingredient in herbal formulations aimed at treating inflammatory and infectious conditions. Phlebitis, which refers to inflammation of a vein, is sometimes addressed in TCM using honeysuckle due to its anti-inflammatory effects.

Scientific research on honeysuckle supports its general anti-inflammatory and antimicrobial properties, attributed mainly to active compounds such as chlorogenic acid and luteolin. Animal and in vitro studies have shown that honeysuckle extracts can inhibit inflammatory mediators and reduce swelling. However, direct clinical evidence for its effectiveness in treating phlebitis specifically is lacking. Most evidence stems from its broad use in TCM for "heat" and "toxicity" conditions, which could be interpreted to include phlebitis or similar inflammatory disorders.

Therefore, the use of honeysuckle for phlebitis is justified primarily by tradition, with some supporting pharmacological rationale but limited direct clinical validation. Evidence rating is moderate (2/5), reflecting the reliance on historical use and preliminary laboratory findings rather than robust, condition-specific clinical trials.

More about honeysuckle
More about Phlebitis